Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

1. Immuno-Oncology Strategic Insight - Multi-Indication And
Market Size Analysis
ASDR-279621

2. Summary
• GlobalData estimates that the total IO market will be worth approximately $14
billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany,
Italy, Spain, UK, and Japan). The main drivers of this growth will come from
immune checkpoint inhibitors, which will have sales of approximately $10 billion
in 2019, rising to $24 billion by 2024. The highest-selling IO drugs by 2024 will
be Opdivo and Keytruda, both PD-1 inhibitors, with sales of approximately $10
billion and $7 billion, respectively. This is because these two drugs will be first-to-
market in many indications, leapfrogging competition such as Roche’s
atezolizumab and AstraZeneca’s durvalumab.

3. Key Findings
• Opdivo will be the biggest selling IO drug by 2024, with approval forecast in
seven indications
• Keytruda will be the second biggest selling IO drug by 2024, with approval
forecast in eight indications
• NSCLC, melanoma, and myeloma will have the greatest contributions to the IO
market in 2019 and 2024
• Novel combinations will allow late-to-market entrants such as durvalumab to
achieve significant sales

4. Reasons To Buy the Report
• Develop and design your in-licensing and out-licensing strategies through a
review of pipeline products and technologies, and by identifying the companies
with the most robust pipeline. Additionally a list of acquisition targets included in
the pipeline product company list.
• Develop business strategies by understanding the trends shaping and driving the
global multiple myeloma therapeutics market.
• Drive revenues by understanding the key trends, innovative products and
technologies, market segments, and companies likely to impact the global
multiple myeloma therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the
competitive landscape and by analysing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create
effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories
and segments that present maximum opportunities for consolidations,
investments and strategic partnerships.

5. More information
Detailed:
– Table of Content
– Full description
– Sample pages
– Etc.
• Go to ASDReports.com and search with: ASDR-279621
ASDR-279621
• Or Google: ASDR-279621

6. About ASDReports
ASDReports.com offers premium market
research on almost every market you can
imagine. We help you to understand what your
market brings you in the future, so that you can
make thoughtful business decisions. We are
dedicated to create a comprehensive offering of
affordable market research you can rely on. Visit
our website to learn more about your current or
future market.

7. Contact
HQ: Amsterdam, the Netherlands
+31 20 486 1286
USA
+1 646 513 4192
Email:
sales@asdreports.com